REFRACTORY CHRONIC COUGH
Clinical trials for REFRACTORY CHRONIC COUGH explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY CHRONIC COUGH trials appear
Sign up with your email to follow new studies for REFRACTORY CHRONIC COUGH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cough pill shows promise in clinical trial
Symptom relief CompletedThis study tested a tablet called nalbuphine ER in 66 adults with refractory chronic cough (a cough lasting over a year with no clear cause). The goal was to see if the drug could reduce how often people coughed over 24 hours. Participants took either the drug or a placebo, then …
Matched conditions: REFRACTORY CHRONIC COUGH
Phase: PHASE2 • Sponsor: Trevi Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New pill shows promise for stubborn cough that Won't quit
Symptom relief CompletedThis study tested an experimental drug called HRS-2261 in 97 adults with refractory chronic cough—a persistent cough that doesn't respond to usual treatments. Participants took the drug or a placebo for 4 weeks to see if it reduced cough severity and improved quality of life. The…
Matched conditions: REFRACTORY CHRONIC COUGH
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC